Burden of osteoarthritis in China, 1990-2019: findings from the Global Burden of Disease Study 2019
- PMID: 38289570
- PMCID: PMC10876716
- DOI: 10.1007/s10067-024-06885-9
Burden of osteoarthritis in China, 1990-2019: findings from the Global Burden of Disease Study 2019
Abstract
This study aimed to report the most current data on the incidence and disability-adjusted life years (DALY) associated with osteoarthritis in China from 1990 to 2019. Publicly available modelled data from Global Burden of Disease Study (GBD) 2019 were used. The incidence and DALY, due to osteoarthritis in China, stratified by sex, trends of associated risk factors, assess the age, period, and cohort effects on the long-term trends of osteoarthritis incidence and DALY in China from 1990 to 2019. We found that the age-standardized incidence and DALY rates of osteoarthritis in China are higher than the average levels in Asia, Africa, and Oceania. In 2019, the number of cases of osteoarthritis in China was 10,681,311, an increase of 132.66% compared with 1990. the DALY of osteoarthritis in China was 4,724,885 person-years, which was 159.70% higher than that in 1990. In 2019, the incidence and DALY rates of osteoarthritis in China was 750.96/100,000,332.19/100,000. High body-mass as risk factors for osteoarthritis DALY with the population attributable proportion (PAF) increasing steadily from 1990 to 2019. The incidence and DALY rates of three types of osteoarthritis from high to low are osteoarthritis knee, osteoarthritis hand, and osteoarthritis hip. Age-period-cohort model showed that the incidence rate of osteoarthritis in China shows a trend of increasing first and then decreasing with age; concurrently, the DALY rate of osteoarthritis in China increased with age. For the period effect, we found that the period rate ratio (RR) of osteoarthritis incidence and DALY rates kept increasing in the cohort born before 2005-2009, and then, it was gradually reduced by year of birth in the cohort born after 2005-2009. As for cohort effect, the cohort RR of incidence rate of osteoarthritis almost has no change, while the cohort RR of DALY rate of osteoarthritis kept increasing from 1990 to 2019. The burden and impact of osteoarthritis in China are substantial and are increasing. Adopting suitable control and preventive community measures to reduce modifiable risk factors is needed to reduce the current and future burden of osteoarthritis in China. Key Points • This paper analyzes the disease burden of osteoarthritis in China for the first time and discusses the influence on the disease burden of osteoarthritis from the perspectives of age, period, and cohort.
Keywords: China; Disability-adjusted life years; Incidence; Osteoarthritis.
© 2024. The Author(s).
Figures





Similar articles
-
[Analysis and prediction of the age-period-cohort model of disease burden of rheumatoid arthritis in China from 1990 to 2019].Zhonghua Nei Ke Za Zhi. 2025 Feb 1;64(2):142-147. doi: 10.3760/cma.j.cn112138-20240328-00200. Zhonghua Nei Ke Za Zhi. 2025. PMID: 39863561 Chinese.
-
Burden evaluation and prediction of osteoarthritis and site-specific osteoarthritis coupled with attributable risk factors in China from 1990 to 2030.Clin Rheumatol. 2024 Jun;43(6):2061-2077. doi: 10.1007/s10067-024-06985-6. Epub 2024 May 2. Clin Rheumatol. 2024. PMID: 38696115
-
Trends in the disease burden of congenital heart disease in China over the past three decades.Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Jun 25;51(3):267-277. doi: 10.3724/zdxbyxb-2022-0072. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 36207836 Free PMC article. English.
-
The global burden of ischemic stroke: findings of the GBD 2010 study.Glob Heart. 2014 Mar;9(1):107-12. doi: 10.1016/j.gheart.2014.01.001. Glob Heart. 2014. PMID: 25432120 Review.
-
The global burden of hemorrhagic stroke: a summary of findings from the GBD 2010 study.Glob Heart. 2014 Mar;9(1):101-6. doi: 10.1016/j.gheart.2014.01.003. Glob Heart. 2014. PMID: 25432119 Review.
Cited by
-
Temporal trends of ischemic stroke attributable to diet high in sodium in China from the global burden of disease study 2021.Front Nutr. 2025 Mar 13;12:1513981. doi: 10.3389/fnut.2025.1513981. eCollection 2025. Front Nutr. 2025. PMID: 40181950 Free PMC article.
-
Global, regional, and national burdens of chronic kidney disease attributable to high body mass index from 1990 to 2021, with future forecasts up to 2050: a systematic analysis for the global burden of disease study 2021.Front Public Health. 2025 Jul 9;13:1612300. doi: 10.3389/fpubh.2025.1612300. eCollection 2025. Front Public Health. 2025. PMID: 40703164 Free PMC article.
-
Study of adiponectin gene (rs1501299) polymorphism and serum adiponectin level in patients with primary knee osteoarthritis.Hum Genomics. 2024 Sep 23;18(1):105. doi: 10.1186/s40246-024-00670-0. Hum Genomics. 2024. PMID: 39313801 Free PMC article.
-
Future perspectives: advances in bone/cartilage organoid technology and clinical potential.Biomater Transl. 2024 Nov 15;5(4):425-443. doi: 10.12336/biomatertransl.2024.04.007. eCollection 2024. Biomater Transl. 2024. PMID: 39872930 Free PMC article. Review.
-
Global, regional, and national burden of early-onset OA attributable to high BMI: 1990-2021 estimates and 2036 projections from the global burden of disease study.PLoS One. 2025 Jul 16;20(7):e0328414. doi: 10.1371/journal.pone.0328414. eCollection 2025. PLoS One. 2025. PMID: 40668785 Free PMC article.
References
-
- Petersen KK, Drewes AM, Olesen AE, Ammitzbøll N, Bertoli D, Brock C, et al. The effect of duloxetine on mechanistic pain profiles, cognitive factors and clinical pain in patients with painful knee osteoarthritis-a randomized, double-blind, placebo-controlled, crossover study. Eur J Pain. 2022;26(8):1650–1664. doi: 10.1002/ejp.1988. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials